Viewing StudyNCT00072358



Ignite Creation Date: 2024-05-05 @ 11:32 AM
Last Modification Date: 2024-10-26 @ 9:09 AM
Study NCT ID: NCT00072358
Status: COMPLETED
Last Update Posted: 2022-05-16
First Post: 2003-11-04

Brief Title: Monoclonal Antibody 3F8 and Sargramostim in Treating Patients With Neuroblastoma
Sponsor: Memorial Sloan Kettering Cancer Center
Organization: Memorial Sloan Kettering Cancer Center

Conditions & Keywords Data

Conditions:
Name
Neuroblastoma
Keywords:
Name View
stage 4S neuroblastoma View
disseminated neuroblastoma View
localized unresectable neuroblastoma View
recurrent neuroblastoma View
regional neuroblastoma View